These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 3015015)

  • 1. Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts.
    Hussy P; Maass G; Tümmler B; Grosse F; Schomburg U
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1073-8. PubMed ID: 3015015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.
    Tabary X; Moreau N; Dureuil C; Le Goffic F
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1925-8. PubMed ID: 2830840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
    Joly-Guillou ML; Bergogne-Berezin E
    Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
    Howard BM; Pinney RJ; Smith JT
    Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novobiocin and nalidixic acid target proteins in yeast.
    Nakayama K; Sugino A
    Biochem Biophys Res Commun; 1980 Sep; 96(1):306-12. PubMed ID: 6254510
    [No Abstract]   [Full Text] [Related]  

  • 6. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mode of action of 4-quinolones and possible mechanisms of resistance.
    Smith JT
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():21-9. PubMed ID: 3542946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.
    Moreau NJ; Robaux H; Baron L; Tabary X
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1955-60. PubMed ID: 1963290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H; Quentin C; de Barbeyrac B; Bebear C
    Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of mammalian DNA synthesis on DNA supercoiling. III. Characterization of the inhibition of replicative and repair-type DNA synthesis by novobiocin and nalidixic acid.
    Mattern MR; Scudiero DA
    Biochim Biophys Acta; 1981 Apr; 653(2):248-58. PubMed ID: 6261824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
    Delmee M; Avesani V
    Antimicrob Agents Chemother; 1986 Feb; 29(2):374-5. PubMed ID: 2940968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases.
    Blanche F; Cameron B; Bernard FX; Maton L; Manse B; Ferrero L; Ratet N; Lecoq C; Goniot A; Bisch D; Crouzet J
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2714-20. PubMed ID: 9124828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus.
    Hoshino K; Sato K; Une T; Osada Y
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1816-8. PubMed ID: 2556080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin.
    Zeiler HJ
    Drugs Exp Clin Res; 1985; 11(5):335-8. PubMed ID: 2941261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro.
    Forsgren A; Schlossman SF; Tedder TF
    Antimicrob Agents Chemother; 1987 May; 31(5):768-73. PubMed ID: 3606076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of DNA gyrase by optically active ofloxacin.
    Imamura M; Shibamura S; Hayakawa I; Osada Y
    Antimicrob Agents Chemother; 1987 Feb; 31(2):325-7. PubMed ID: 3032098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.